Close
Nordic 9Nordic 9

Third Rock Ventures (investor - Venture Capital)

United States thirdrockventures.com
See something wrong or missing? Let us know
Offices:Boston

Third Rock Ventures is a Boston, USA-based healthcare venture firm focused on advancing disruptive areas of science and medicine

Average round investment:111M USD
Average number per year:1.0
Distribution: 2025 (1)2023 (1)
Portfolio companies: Norway Artbio
Mostly invests in: Norway Norway (2) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Third Rock Ventures

Name Criteria
Denmark PKA
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Axcel
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Norway p53 Invest
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Surveyor Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Maj Invest
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Intermediate Capital Group
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Omega Funds
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
United States Alexandria Venture Investments
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Qatar Qatar Investment Authority
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Sweden Nordic Capital
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top